|

AUD/USD defends dollar-led bounce off two-week low under 0.7200, yields, coronavirus eyed

  • AUD/USD holds onto Friday’s corrective pullback from 13-day low.
  • Market sentiment remains weak but NFP disappointment weighed down the greenback.
  • Australia starts vaccines for children between 05-12, Queensland delays school reopening.
  • Aussie Building Permits for November eyed for short-term direction, US CPI and Retail Sales are the key for week.

AUD/USD begins the second trading week of 2022 without surprises, keeping Friday’s rebound from a nearly two-week bottom around 0.7180 during early Monday morning in Asia.

Mixed prints of the US employment data for December triggered the biggest daily fall of the US Dollar Index in six weeks the previous day. The greenback’s weakness favored commodities and Antipodeans. However, a second thought on the jobs report termed it mostly in line with the Fed’s expectations and kept the rate hike woes on the table, which in turn curbed the USD losses while also weighing on the equities and favoring the Treasury bond yields.

The headline Nonfarm Payrolls (NFP) disappointed markets with 199K figures for December versus 400K forecasts and 249K prior (upwardly revised from 210K). However, the Unemployment Rate dropped to 3.9% compared to 4.1% market consensus and 4.2% in November while the U6 Underemployment Rate that fell to 7.3% against November's downwardly revised 7.7%, both closing in the pre-pandemic levels. It’s worth noting that an NFP-led disappointment was largely overruled by the Unemployment Rate and U6 Underemployment Rate.

Following the data, the US dollar and the Treasury yields dropped, helping the equities and commodities. However, the day-end readings portrayed bearish bias on Wall Street and firmer US bond yields, despite the US dollar’s failure to rebound.

Elsewhere, Australia begins vaccinations for 05-12 years children from Monday after witnessing the record high infections, despite the latest figures eased. The virus pushes Queensland to delay the yearly school reopening by a month to early February. Not only at home but the virus conditions are getting worst elsewhere even as policymakers cite scientific studies to stay hopeful.

It should be observed that hopes of US stimulus were also a positive catalyst that largely got ignored.

On a different page, the US-China tussles continue, recently over trade and the human rights issues while Russia-Ukraine matter gains major attention ahead of this week’s Washington-Moscow meeting.

Amid these plays, the AUD/USD pair remains vulnerable to the further downside even as the US dollar led recent rebound of the pair. Hence, traders will look for possible bearish hints, which in turn highlight the key risk catalysts like the covid updates and geopolitical news as the economic calendar is mostly silent for Monday, except for Australia Building Permits for November, expected 0.0% versus -12.9% prior.

Technical analysis

Despite bouncing off 23.6% Fibonacci retracement of (Fibo.) October-December downside, AUD/USD remains below stays below 20-DMA level surrounding 0.7195, not to forget keeping the pullback from the 100-DMA, near 0.7290 at the latest. The inability to cross the key moving averages joins the receding bullish bias of the MACD and steady RSI to keep sellers hopeful.

That said, fresh downside will aim for the 23.6% Fibo. retest, around 0.7125, ahead of targeting a horizontal area from August 20 near 0.7110-05.

Additional important levels

Overview
Today last price0.7178
Today Daily Change-0.0004
Today Daily Change %-0.06%
Today daily open0.7182
 
Trends
Daily SMA200.7195
Daily SMA500.7227
Daily SMA1000.7288
Daily SMA2000.7435
 
Levels
Previous Daily High0.7189
Previous Daily Low0.713
Previous Weekly High0.7278
Previous Weekly Low0.713
Previous Monthly High0.7278
Previous Monthly Low0.6993
Daily Fibonacci 38.2%0.7166
Daily Fibonacci 61.8%0.7152
Daily Pivot Point S10.7145
Daily Pivot Point S20.7107
Daily Pivot Point S30.7085
Daily Pivot Point R10.7204
Daily Pivot Point R20.7226
Daily Pivot Point R30.7264

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Editor's Picks

EUR/USD retakes 1.1800 on renewed USD weakness

EUR/USD gains ground after three days of losses, re-attempting 1.1800in the European trading hours on Thursday. The US Dollar sees fresh selling interest across the board, despite hawkish Fed Minutes, as the market mood improves and supports the pair. US Jobless Claims data, Fedspeak and geopolitics remain in focus. 

GBP/USD recovers above 1.3500 amid better mood

GBP/USD finds fresh demand and rises back above 1.3500 in the European session on Thursday. Improving risk sentiment and renewed US Dollar weakness are helping the pair recover ground ahead of mid-tier US data releases and Fedspeak. 

Gold clings to gains above $5,000 amid safe-haven flows and Fed rate cut bets

Gold sticks to modest intraday gains, above the $5,000 psychological mark, through the first half of the European session, though it lacks bullish conviction amid mixed cues. The third round of US-mediated negotiations between Ukraine and Russia concluded in Geneva on Wednesday without any major breakthrough.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.